Reliance Chemotex Industries Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

Stock Performance and Market Context

On 27 Jan 2026, Reliance Chemotex Industries Ltd’s share price fell sharply, registering a day change of -4.16%, and settling at its lowest point in the past year. This movement comes amid a broader market environment where the Sensex opened 100.91 points lower and was trading at 81,298.09, down 0.29%. The Sensex itself has been on a three-week consecutive decline, losing 2.73% over this period. Notably, other indices such as NIFTY MEDIA and NIFTY REALTY also hit new 52-week lows on the same day, indicating sector-wide pressures.

The stock’s performance has been notably weaker than the sector, underperforming by 100.67% today. Additionally, Reliance Chemotex has experienced erratic trading, having not traded on one day out of the last 20, which may reflect liquidity concerns or investor caution. The stock is currently trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained downtrend.

Long-Term Performance and Financial Metrics

Over the last year, Reliance Chemotex Industries Ltd has delivered a negative return of 35.76%, in stark contrast to the Sensex’s positive 7.89% gain over the same period. This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index over the past three years, one year, and three months.

From a fundamental perspective, the company’s long-term financial strength remains subdued. The average Return on Capital Employed (ROCE) stands at 9.25%, which is modest relative to industry standards. Net sales have grown at an annual rate of 8.44% over the last five years, while operating profit has increased at 17.83% annually. Despite these growth figures, the company’s ability to service its debt is limited, with a high Debt to EBITDA ratio of 4.66 times, indicating elevated leverage levels.

Recent Quarterly and Nine-Month Results

Despite the stock’s downward trajectory, Reliance Chemotex Industries Ltd has reported positive results for the last three consecutive quarters. The company’s Profit After Tax (PAT) for the nine-month period stands at ₹4.55 crores, reflecting a robust growth rate of 84.21%. Quarterly net sales reached a high of ₹99.52 crores, marking the highest level recorded in recent periods.

However, the company’s ROCE for the recent period has declined to 4.5%, which is below its long-term average. This lower capital efficiency is juxtaposed with a very attractive valuation metric, as the stock’s Enterprise Value to Capital Employed ratio is 0.9, suggesting that the market is pricing the company at a discount relative to its capital base.

Valuation and Comparative Metrics

Reliance Chemotex Industries Ltd is trading at a valuation discount compared to its peers’ average historical valuations. The company’s Price/Earnings to Growth (PEG) ratio stands at 0.2, indicating that the stock’s price is low relative to its earnings growth rate. This valuation metric is notable given the company’s profit growth of 87.4% over the past year, despite the share price decline of 35.76% during the same period.

The majority shareholding remains with the promoters, which often provides a degree of stability in ownership structure. The company’s market capitalisation grade is rated 4, reflecting its size and market presence within the Garments & Apparels sector.

Mojo Score and Rating Changes

The company’s Mojo Score currently stands at 37.0, with a Mojo Grade of Sell. This represents an upgrade from the previous Strong Sell rating, which was revised on 25 Aug 2025. The adjustment in rating reflects some improvement in recent financial results, though the overall outlook remains cautious given the stock’s price behaviour and fundamental metrics.

Sector and Index Comparisons

Within the Garments & Apparels industry, Reliance Chemotex Industries Ltd’s performance contrasts with broader sector trends. The Sensex, while experiencing a mild decline, remains above its 200-day moving average, although it is trading below its 50-day moving average. This technical setup indicates some near-term weakness in the market but not a full-scale downturn. The stock’s persistent trading below all major moving averages highlights its relative weakness compared to the benchmark.

Reliance Chemotex’s 52-week high was ₹217.35, illustrating the extent of the stock’s decline to its current low. The gap between the high and the recent low emphasises the volatility and challenges faced by the company over the past year.

Summary of Key Financial and Market Indicators

To summarise, Reliance Chemotex Industries Ltd’s key metrics include:

• 52-week low reached on 27 Jan 2026, with a day decline of -4.16%


• One-year return of -35.76% versus Sensex’s +7.89%


• Average ROCE of 9.25% over five years, with recent decline to 4.5%


• Debt to EBITDA ratio of 4.66 times, indicating high leverage


• Net sales growth at 8.44% annually over five years


• Operating profit growth at 17.83% annually over five years


• Profit after tax growth of 84.21% over nine months


• Enterprise Value to Capital Employed ratio of 0.9, suggesting valuation discount


• PEG ratio of 0.2, reflecting low price relative to earnings growth


• Mojo Score of 37.0 and current rating of Sell, upgraded from Strong Sell

These figures collectively illustrate a company facing headwinds in market valuation and price performance, despite some positive earnings growth and recent quarterly results.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →